Selected Patients With Peritoneal Metastases From Breast Cancer May Benefit From Cytoreductive Surgery: The Results of a Multicenter Survey

Selected Patients With Peritoneal Metastases From Breast Cancer May Benefit From Cytoreductive Surgery: The Results of a Multicenter Survey

BackgroundEven though breast cancer is the most frequent extra-abdominal tumor causing peritoneal metastases, clear clinical guidelines are lacking. Our aim is to establish whether cytoreductive surgery (CRS) could be considered in selected patients with peritoneal metastases from breast cancer (PMB...

Full description

Bibliographic Details
Main Authors: Maurizio Cardi, Marc Pocard, Rea Lo Dico, Gianmaria Fiorentini, Mario Valle, Roberta Gelmini, Marco Vaira, Enrico Maria Pasqual, Salvatore Asero, Gianluca Baiocchi, Andrea Di Giorgio, Alessandra Spagnoli, Francesco Di Marzo, Bianca Sollazzo, Giuseppe D’Ermo, Daniele Biacchi, Franco Iafrate, Paolo Sammartino
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
breast cancer
peritoneal metastases
cytoreductive surgery
oligometastatic disease
ascites treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.822550/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.822550/full

Similar Items